Shield Therapeutics plc (FRA:1JS)
0.1050
-0.0140 (-11.76%)
At close: Jan 5, 2026
Revenue by Product
Financials in millions GBX. Fiscal year is January - December.
Millions GBX. Fiscal year is Jan - Dec.
Revenue by Geography
Financials in millions GBX. Fiscal year is January - December.
Millions GBX. Fiscal year is Jan - Dec.